1.1371
price down icon1.12%   -0.0129
after-market Handel nachbörslich: 1.14 0.0029 +0.26%
loading

Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten

pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Increases Stake in Dermata Therapeutics I - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Dermata Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Dermata Therapeutics stock hits 52-week low at $1.2 amid steep decline - Investing.com UK

Nov 14, 2024
pulisher
Nov 13, 2024

Earnings Flash (DRMA) DERMATA THERAPEUTICS Reports Q3 Loss $-2.04 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - AccessWire

Nov 13, 2024
pulisher
Nov 13, 2024

Dermata Hits 50% Enrollment in Phase 3 Acne Trial, Raises $7.8M in 2024 | DRMAW Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 11, 2024

Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024 - The Manila Times

Nov 11, 2024
pulisher
Nov 05, 2024

Dermata stock hits 52-week low at $1.22 amid market challenges - Investing.com Australia

Nov 05, 2024
pulisher
Oct 26, 2024

Sponge Power: Dermata's Revolutionary Acne Treatment Trial Results Due In 2025 - RTTNews

Oct 26, 2024
pulisher
Oct 17, 2024

Analyzing DRMA’s price-to-book ratio for the last quarter - US Post News

Oct 17, 2024
pulisher
Oct 14, 2024

Dermata stock hits 52-week low at $1.28 amid market challenges - Investing.com UK

Oct 14, 2024
pulisher
Oct 10, 2024

Acne Vulgaris Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2024-2034), States DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health - Barchart

Oct 10, 2024
pulisher
Oct 08, 2024

Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024 - AccessWire

Oct 08, 2024
pulisher
Sep 23, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 3.2% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

How does Dianthus Therapeutics Inc (DNTH) change from a tortoise to a hare? - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Ameritas Investment Partners Inc. Has $1.82 Million Stake in Dolby Laboratories, Inc. (NYSE:DLB) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

How to interpret Design Therapeutics Inc (DSGN)’s stock chart patterns - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

The Dixie Group (NASDAQ:DXYN) Earns Hold Rating from Analysts at StockNews.com - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Darden Restaurants, Inc. (NYSE:DRI) Holdings Raised by XTX Topco Ltd - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Darden shares steady on neutral rating from Piper Sandler - Investing.com India

Sep 21, 2024
pulisher
Sep 21, 2024

Darden stock 'ready to run' with delivery boost and sales initiativesBTIG By Investing.com - Investing.com South Africa

Sep 21, 2024
pulisher
Sep 20, 2024

Ensysce Biosciences (NASDAQ:ENSC) Stock Quotes, Forecast and News Summary - Benzinga

Sep 20, 2024
pulisher
Sep 20, 2024

Argent Trust Co Has $533,000 Stock Position in Darden Restaurants, Inc. (NYSE:DRI) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Diamondback Energy 12.77M share Spot Secondary priced at $178.00 - TipRanks

Sep 20, 2024
pulisher
Sep 20, 2024

Darden price target raised to $195 from $185 at Truist - TipRanks

Sep 20, 2024
pulisher
Sep 19, 2024

Dianthus Therapeutics (NASDAQ:DNTH) Trading Up 7.5% - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Analytical Overview: Dermata Therapeutics Inc (DRMA)’s Ratios Tell a Financial Story - The Dwinnex

Sep 19, 2024
pulisher
Sep 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - Kilgore News Herald

Sep 18, 2024
pulisher
Sep 18, 2024

A Look at Dermata Therapeutics Inc (DRMA) Shares in the Recent Past Indicates Growth - SETE News

Sep 18, 2024
pulisher
Sep 17, 2024

Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - StockTitan

Sep 17, 2024
pulisher
Sep 17, 2024

Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - StockTitan

Sep 17, 2024
pulisher
Sep 17, 2024

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 17, 2024
pulisher
Sep 16, 2024

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga

Sep 16, 2024
pulisher
Sep 16, 2024

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 16, 2024
pulisher
Sep 13, 2024

Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga

Sep 13, 2024
pulisher
Sep 12, 2024

Acne Vulgaris Market Size is Set for Rapid Growth as Innovative - openPR

Sep 12, 2024
pulisher
Sep 05, 2024

Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - StockTitan

Sep 05, 2024
pulisher
Sep 02, 2024

Prepare Yourself for Liftoff: Dermata Therapeutics Inc (DRMA) - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Can you now get a good deal on Dermata Therapeutics Inc’s shares? - US Post News

Sep 02, 2024
pulisher
Sep 02, 2024

Daily Market Movement: Dermata Therapeutics Inc (DRMA) Sees a 1.16 Increase, Closing at 1.74 - The Dwinnex

Sep 02, 2024
pulisher
Aug 27, 2024

Axillary Hyperhidrosis Market Expected to Experience Major - openPR

Aug 27, 2024
pulisher
Aug 21, 2024

Maxim cuts Dermata Therapeutics stock target, retains buy on dilution risk - Investing.com India

Aug 21, 2024
pulisher
Aug 21, 2024

Maxim Group Lowers Dermata Therapeutics (NASDAQ:DRMA) Price Target to $6.00 - Defense World

Aug 21, 2024
pulisher
Aug 08, 2024

Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Lags Revenue Estimates - MSN

Aug 08, 2024
pulisher
Aug 07, 2024

Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - Yahoo Finance

Aug 07, 2024
pulisher
Aug 06, 2024

3 Penny Stocks to Watch Now, 8/6/24 - TipRanks

Aug 06, 2024
pulisher
Aug 05, 2024

Take off with Dermata Therapeutics Inc (DRMA): Get ready for trading - SETE News

Aug 05, 2024
pulisher
Aug 03, 2024

Dermata Therapeutics expands offering by $505,000 - Investing.com Australia

Aug 03, 2024
pulisher
Aug 02, 2024

Dermata Therapeutics Inc [DRMA] moved up 44.19: Why It’s Important - The DBT News

Aug 02, 2024
pulisher
Aug 02, 2024

Daily Market Movement: Dermata Therapeutics Inc (DRMA) Sees a 44.19 Increase, Closing at 2.48 - The Dwinnex

Aug 02, 2024
pulisher
Aug 01, 2024

Why did Dermata Therapeutics Inc (NASDAQ: DRMA) surge today ? - BP Journal

Aug 01, 2024
pulisher
Aug 01, 2024

DRMA’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle

Aug 01, 2024
pulisher
Aug 01, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.21% - Investing.com

Aug 01, 2024
pulisher
Jul 28, 2024

Dermata Therapeutics, Inc. (NASDAQ:DRMA) Short Interest Up 141.3% in July - Defense World

Jul 28, 2024
pulisher
Jul 27, 2024

Windtree Therapeutics (WINT) Advancing Cardiac Innovation with Istaroxime - BP Journal

Jul 27, 2024
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Kapitalisierung:     |  Volumen (24h):